Search
What’s more shocking than a fake online pharmacy selling fake medicines to desperate patients? The same sites selling illicit drugs like fentanyl. It’s one more reason to support the DRUGS Act.
Read MoreA high school senior who died in 2021 believed he was buying oxycodone, but test results showed fentanyl and xylazine—a non-opioid veterinary sedative.
Find links to this story and two dozen more in this week’s news roundup.
Read MoreNew Jersey is the 17th state in which PSM has documented a death caused by a counterfeit pill containing fentanyl sold to the victim on Snapchat.
Read MoreIt doesn’t matter whether you live in United States, Europe, Asia, or Africa-everyone is at risk from unsafe drugs. Counterfeit drugs defraud consumers and deny patients therapies that can alleviate suffering and save lives. In some cases, these drugs have caused great harm and fatalities. Take a moment to learn how you can minimize your risk of getting a counterfeit…
Read MoreThe U.S. Food and Drug Administration (FDA) is warning people not to use the SD Biosensor Inc. STANDARD Q COVID-19 Ag Home Test. The test is not authorized, cleared, or approved by the FDA for distribution or use in the United States. The FDA is concerned about the risk of false results when using this unauthorized test. This unauthorized test may be packaged in a white and magenta box.
Read MoreLearn how this year’s Notorious Markets Report illustrates need for the DRUGS Act.
Read MoreLegitScript’s three-month study found that locking and suspending rogue online pharmacy websites suppressed them in search engine results.
Catch up on this and more than 30 other stories here.
Read MoreIn this February 24, 2022 editorial published on the Connecticut Business & Industry Association’s website, Paul Pescatello reviews the practical reasons that mean that importing drugs from Canada will not lower prescription drug prices. Pescatello is the executive director of CBIA’s Bioscience Growth Council and chair of We Work for Health Connecticut.
Read MoreWashington, D.C. (August 12, 2021) – Shabbir Safdar, executive director of the Partnership for Safe Medicines, released the following statement in response to the Synthetic Opioid Trafficking Commission’s Final Report
Read MoreThe Commission on Combating Synthetic Opioid Trafficking’s Final Report makes recommendations for a complex, multipronged federal response to the fentanyl crisis.
Read More